(Q40617558)

English

Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis

scientific article published on December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

based on heuristic

inferred from title

Yosuf El Shabrawi

1

object named as

Yosuf El-Shabrawi

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Josef Hermann

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

2342-2346

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

The possible impact of uveitis in blindness: a literature survey

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes in anterior uveitis associated with the HLA-B27 haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Report on the 4th International Symposium of Ocular Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of cytokines and chemokines in uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Riding on a carousel with IFN-alpha and TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept therapy in children with treatment-resistant uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901292-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(02)01292-7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40617558&oldid=2047616974"